These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 8582889

  • 1. A new HIV/AIDS drug.
    J Ark Med Soc; 1996 Jan; 92(8):407. PubMed ID: 8582889
    [No Abstract] [Full Text] [Related]

  • 2. 3TC approval may revive AZT's appeal.
    Vazquez E.
    Posit Aware; 1996 Jan; 7(1):8-9. PubMed ID: 11363136
    [Abstract] [Full Text] [Related]

  • 3. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [Abstract] [Full Text] [Related]

  • 4. Lamivudine as adjunct therapy in HIV.
    Am Fam Physician; 1996 Feb 01; 53(2):781-2. PubMed ID: 8629550
    [No Abstract] [Full Text] [Related]

  • 5. Roaches of inner space.
    Gilden D.
    GMHC Treat Issues; 1995 Oct 01; 9(10):1, 14-6. PubMed ID: 11362912
    [Abstract] [Full Text] [Related]

  • 6. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
    James JS.
    AIDS Treat News; 1995 Dec 22; (no 237):3. PubMed ID: 11363075
    [Abstract] [Full Text] [Related]

  • 7. 3TC/AZT: just another combination.
    GMHC Treat Issues; 1995 Dec 22; 9(12):2. PubMed ID: 11362997
    [Abstract] [Full Text] [Related]

  • 8. Another protease inhibitor proves highly effective.
    Prescott LM.
    Posit Aware; 1996 Dec 22; 7(5):11. PubMed ID: 11363781
    [Abstract] [Full Text] [Related]

  • 9. FDA triple header. Food and Drug Administration.
    Smart T.
    GMHC Treat Issues; 1995 Nov 22; 9(11):1-3. PubMed ID: 11362986
    [Abstract] [Full Text] [Related]

  • 10. [What should be done after needlestick injuries with possible HIV exposure?].
    Marcus U.
    Fortschr Med; 1996 Feb 10; 114(4):23-4. PubMed ID: 8852682
    [No Abstract] [Full Text] [Related]

  • 11. 3TC and AZT.
    Treat Rev; 1995 Feb 10; (no 17):2. PubMed ID: 11362294
    [Abstract] [Full Text] [Related]

  • 12. Protease inhibitors shine in triple combinations.
    AIDS Alert; 1996 Mar 10; 11(3):31-2. PubMed ID: 11363243
    [Abstract] [Full Text] [Related]

  • 13. HIV's Achilles' heel. Drugs and education are starting to slow the AIDS virus.
    Beardsley T.
    Sci Am; 1996 Sep 10; 275(3):16, 18. PubMed ID: 8701287
    [No Abstract] [Full Text] [Related]

  • 14. Three-drug combos.
    Posit Aware; 1996 Sep 10; 7(1):6. PubMed ID: 11363125
    [Abstract] [Full Text] [Related]

  • 15. A surprisingly potent nucleoside analogue.
    Torres G.
    GMHC Treat Issues; 1996 Feb 10; 10(2):8. PubMed ID: 11363384
    [Abstract] [Full Text] [Related]

  • 16. Lamivudine (3TC) approved for combination use with AZT.
    James JS.
    AIDS Treat News; 1995 Dec 01; (no 236):1-5. PubMed ID: 11363049
    [Abstract] [Full Text] [Related]

  • 17. Top AIDS researchers' strategy for antiretroviral treatment.
    AIDS Alert; 1996 Sep 01; 11(9):97-100. PubMed ID: 11363728
    [Abstract] [Full Text] [Related]

  • 18. New developments in antiretroviral drug therapy for HIV-1 infections.
    Johnson VA.
    AIDS Clin Rev; 1996 Sep 01; ():305-46. PubMed ID: 7488558
    [No Abstract] [Full Text] [Related]

  • 19. Triple combination superior to double combination.
    Grodeck B.
    Posit Aware; 1995 Sep 01; ():6. PubMed ID: 11362210
    [Abstract] [Full Text] [Related]

  • 20. Protease inhibitors and prevention of cross resistance.
    Levin J.
    AIDS Treat News; 1995 Oct 06; (no 232):1-3. PubMed ID: 11362875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.